IGF-I Antibody

Primary Antibodies, Functional Antibodies, Antibody Pairs

Room Temp

Growth Factor, Antibody Pairs, Functional Assays

None

Anti-hIGF-1 specific antibody was purified by affinity chromatography employing immobilized hIGF-1 matrix.

Neutralization:
To yield one-half maximal inhibition [ND50] of the biological activity of hIGF-1 (3.00 ng/mL), a concentration of 0.67 0.1 μ g/mL of this antibody is required.
ELISA:
To detect hIGF-1 by direct ELISA (using 100 μ L/well antibody solution) a concentration of at least 0.5 μ g/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with compatible secondary reagents, allows the detection of 0.2 - 0.4 ng/well of recombinant hIGF-1.
Sandwich:
To detect hIGF-I by sandwich ELISA (using 100 μ L/well antibody solution) a concentration of 0.5 - 2.0 μ g/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with our Biotinylated Anti-Human IGF-I (XP-5158Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIGF-I.
Western Blot:
To detect hIGF-1 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μ g/mL. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-1 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

Polyclonal

Homo sapiens

Centrifuge vial prior to opening.